INCYTE CORP (INCY)
INCYTE CORP (INCY) from its SEC filings: 2025 revenue $5.1 billion (+21% vs the year before), net margin 25%, free cash flow $1.4 billion. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Services-Commercial Physical & Biological Research |
| Revenue (2025) | $5.1 billion |
| Revenue growth | +21% |
| Net income | $1.3 billion |
| Net margin | 25.0% |
| Free cash flow | $1.4 billion |
| Diluted EPS | $6.41 |
| Latest quarter (Q1 2026 (calendar)) revenue vs a year earlier | +21% |
| Cash | $3.5 billion |
| Long-term debt | $316.2 million |
| Share count, 1 year | +3% |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-24. Education only, not financial advice.